Power Law company profile

Karyopharm Therapeutics

Biotech & Life Sciences · Newton, United States · Founded 2008 · IPO 2013 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$359M

Market cap · Apr/2026

Revenue

$145M

Latest reported FY

Investors

4 investors on Karyopharm Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 4 investors entered at this stage

Global footprint

AI talent share

1.3% of workforce is AI talent
(4 of 313 staff)

Core AI00%

Other AI41.28%

Non-AI workforce30998.72%

Web traffic by country

8.9K monthly visits
across markets

🇺🇸 United States67.4%

🇨🇦 Canada11.2%

🇮🇳 India10.1%

🇬🇧 United Kingdom10.1%

Top 4 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo